ARK Genomic Revolution Multi-Sector ETF (ARKG) ETF

Expense Ratio: 0.75% | AUM: 10.13M | Issuer: Ark Funds

ARKG Daily Price Range
ARKG 52-Week Price Range

ARKG - Real-Time SMART Grade™

A
Strong Buy

Overall SMART Grade

ARKG has a real-time SMART Grade of A (Strong Buy).

Learn More About SMART Grades™

ARKG - Profile & Info


The investment objective of the ARK Genomic Revolution Multi-Sector ETF seeks to invest in companies substantially focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, improvements and advancements in genomics into their business. One such way this is accomplished is by offering new products or services that rely on genomic sequencing, analysis, synthesis or instrumentation. These companies may develop, produce or enable: Agricultural Biology, Bioinformatics, Bionic Medicine, DNA Sequencing, Instrumentation, Stem Cells, Pharmaceutical Innovation, Molecular Medicine and Diagnostics, and Bio-inspired Computing. The Fund is concentrated in any industry or group of industries in the health care sector, including, in particular, issuers having their principal business activities in the biotechnology industry. Other industries in the health-care sector include medical laboratories and research, drug manufacturers and agricultural chemicals.

Issuer Ark Funds
Expense Ratio 0.75%
Assets Under Management (AUM) 10.13M
Asset Class Equity
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $20.05
Options? No
Total Holdings N/A

ARKG - Price/Volume Stats

Current price $20.66
Prev. close $20.66
Day low $20.52
Day high $20.80
52-week high $20.94
52-week low $15.85
Day Volume 17,300
Avg. volume 5,182
Dividend yield N/A

ARKG - Recent Returns

1-mo 4.08%
3-mo 8.39%
6-mo 11.56%
1-year 21.10%
3-year N/A
5-year N/A
YTD 22.03%
2016 -19.23%
2015 -1.27%
2014 N/A
2013 N/A
2012 N/A

ARKG - Stock Chart


Page generated in 2.0222 seconds.